This federal contract award is for the delivery of Gralise ER 300 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,209.43. The contract has a period of performance through December 13, 2024 and utilizes a firm fixed-price pricing structure.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is one of many that fall under the broader IDC. The contract does not have a set-aside designation, indicating open competition.
Generated 3/16/25, 12:54 AM